Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Clinical trial NCT07572396 · RECRUITING

Trial details

NCT number: NCT07572396
Sponsor: Amplexd Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-risk HPV (Any Strain)LSIL, Low Grade Squamous Intraepithelial Lesion ASC-US HPV Infection Cervical Abnormalities Uterine Cervical Dysplasia

Start date: 2026-04-30
Primary completion: 2026-12-27
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.